Affiliation:
1. University of Brasilia, Brazil
Abstract
Onychomycosis is a common disease, accounting for up to 50% of all ungual pathologies. We have been developing a clinical trial (ClinicalTrials.gov: NCT01528813) using a 2940nm Er:YAG laser to fractionally ablate human nails in vivo, aiming to increase topical amorolfine lacquer delivery to the nail unit, increasing the efficacy of topical treatment of distal and lateral subungual onychomycosis. Partial results have shown an increase in areas of nail plate free of disease. We believe that ablative lasers can increase the efficacy of topical onychomycosis treatment.
Reference5 articles.
1. Occurrence of onychomycosis among patients attended in dermatology offices in the city of Rio de Janeiro, Brazil;Araújo AJG;An Bras Dermatol,2003
2. New therapeutic options for onychomycosis;Gupta AK;Expert Opin Pharmacother,2012
3. Nail abrasion;Di Chiacchio N;J Cosmet Dermatol,2003
4. Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis;Sumikawa M;J Dermatol,2007
5. Ablation of human nail by pulsed lasers;Neev J;Lasers Surg Med,1997
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献